McGivney Global Advisors has contracted with 33 different biopharma companies in 2026.

McGivney Global Advisors was founded by William T. McGivney, PhD, former CEO of National Comprehensive Cancer Network and former Vice President, Clinical and Coverage Policy for Aetna Health Plans. McGA is a different kind of consulting firm, focused on bringing real-world expertise from leaders in health policy, pharmaceutical reimbursement and market access, and cancer care to decision-makers in pharma/biotech companies, investment houses, major law firms, and national associations. McGivney Global Advisors works with client companies to identify the real issues impacting their businesses, provide in-depth and actionable analyses, and develop actionable and impactful strategies to facilitate optimal product positioning for the success of innovative products. The McGivney Global Advisors team has a broad and deep track-record with demonstrable achievements and impact on practice standards, coverage policies, informatics platforms, and the application of data in health care decision-making. McGivney has a keen sense of what really matters in the complex, fast-paced world of policy-setting and decision-making, helping clients cut through the sea of buzzwords to navigate the real world impact of policy and payers.